One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 8, 2007, Pages 859-865

  Wister, Andrew V ^a   Loewen, Nadine ^b   Kennedy Symonds, Holly ^c   McGowan, Brian ^c   McCoy, Bonnie ^d   Singer, Joel ^e  

^a SIMON FRASER UNIVERSITY   (Canada)

^b Fraser Health Authority   (Canada)

^c Burnaby Hospital   (Canada)

^d BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COUNSELING; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NUTRITION; PATIENT CARE; SCORING SYSTEM; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; TELEHEALTH;

EID: 35348999106     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.061059     Document Type: Article

References (30)

1. Heart and Stroke Foundation of Canada. The growing burden of heart disease and stroke in Canada. Ottawa: The Foundation; 2003.
2. Chen J, Millar WJ. Are recent cohorts healthier than their predecessors? Health Rep 2000;11(4):9-23.
3. Wister AV. Baby boomer health dynamics: How are we aging?Totonto: University of Toronto Press; 2005.
4. DeBusk RF, Miller NH, Superko R, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 1994;120:721-9.
5. Gordon NF, Salmon RD, Franklin BA, et al. Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia. Am J Cardiol 2004;94:1558-61.
6. Haskell WL, Alderman EL, Fair JM, et al. Effects of multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994;89:975-90.
7. Knoops KT, de Groot LC, Kromhout D, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE Project. JAMA 2004;292:1433-9.
8. Stampfer MJ, Hu FB, Manson JE, et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16-22.
9. Expert Patients Task Force. The expert patient: a new approach to chronic disease management for the 21st century. London (UK): Department of Health; 2000.
10. Lear SA, Ignaszewski A, Linden W, et al. The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial. Eur Heart J 2003;24:1920-7.
11. Wing RR, Goldstein M, Acton K, et al. Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care 2001;24:117-23.
12. O'Connor B, Cameron R, Farquharson J, et al. Marketing the heart health vision -delivering the "preventive dose." Ottawa: WHO Collaborating Centre for Policy Development in the Prevention of Noncommunicable Disease; 2000.
13. Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999;100:1481-92.
14. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
15. Canadian Community Health Survey (CCHS 3.1). Risk factors for heart disease in midlife (45-64 years). Fraser Health. Ottawa: Statistics Canada. 2005.
16. Grundy SM, Becker D, Clark LT. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): executive summary. NIH Publ. no. 01-3670. Washington (DC): National Institutes of Health, National Heart, Lung, and Blood Institute; 2001. Available: www.nhlbi.nih.gov/guidelines/cholesterol/atp_iii.htm (accessed 2001 Sep 10).
17. Genest J Jr, Frohlich J, Fodor G, et al. Guidelines for the management and treatment of dyslipidemia and prevention of cardiovascular disease: summary of the 2003 update. CMAJ 2003;169:921-4.
18. Canadian Association of Cardiac Rehabilitation. Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention. Enhancing the science, refining the art. 2nd ed. Winnipeg: The Association; 2004.
19. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2000.
20. Marcus BH, Bock BC, Pinto BM. Initiation and maintenance of exercise behavior. In: Gochman DS, editor. Handbook of health behavior research II: Provider determinants. New York: Plenum Press; 1997. p. 336-9.
21. Marcus BH, Selby VC, Niaura RS, et al. Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport 1992;63:60-6.
22. Clinical practice guideline. Treating tobacco use and dependence. Washington: US Department of Health and Human Services, Public Health Service; 2000.
23. BC Doctors Stop Smoking Program. A program of the Society for Clinical Preventive Health Care. Vancouver: Society for Clinical Preventive Health Care; 2001. Available: www.bcdssp.com (accessed 2001 Nov 15).
24. 2 t Program (Health Education and Risk Reduction Training Program). Stanford (CA): Stanford University, Stanford Center for Research in Disease Prevention; 2001.
25. Canada's food guide to healthy eating for people four years and over. Ottawa: Health Canada; 1997.
26. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection. Med Care 1992;30:473-83.
27. Hingorani AD, Vallance P. A simple computer program for guiding management of cardiovascular risk factors and prescribing. BMJ 1999;318:101-5.
28. Lipsey M. Design sensitivity: statistical power for experimental research. New York: Sage; 1990.
29. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ 1999;319:670-4.
30. Fergusson D, Aaron SD, Guyatt G, et al. Post-randomization exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325:652-4.